Can Fite BioPharma Ltd (CANF): Can-Fite to Share with Investors Latest...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	145
Posts	27561
Boards Moderated	3
Alias Born	02/07/2004

midastouch017

Re: None

Thursday, 09/07/2023 8:21:05 AM

Thursday, September 07, 2023 8:21:05 AM

Can-Fite to Share with Investors Latest Oncology and Rare Genetic Disease Developments at the H.C. Wainwright 25th Annual Conference

https://finance.yahoo.com/news/fite-share-investors-latest-oncology-110000778.html

Thu, September 7, 2023 at 2:00 PM GMT+3

PETACH TIKVA, Israel, September 07, 2023--(BUSINESS WIRE)--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncology, inflammatory and liver diseases, today announced that the Company’s CEO Motti Farbstein will present at the H.C. Wainwright 25th Annual Conference. In addition to the presentation, he will conduct one-on-one meetings with investors at the conference.
Motti Farbstein will highlight Can-Fite’s advanced stage pipeline including the pancreatic carcinoma and the rare genetic disease Lowe Syndrome latest developments on September 11th. An updated company presentation has been uploaded to the company website.